|
ALNYLAM PHARMACEUTICALS, INC. |
Arbuckle Stuart A |
Director
|
2026-01-05 |
A - A |
3,279 |
0.00 |
0.00 |
3,279 |
| RCUS |
Arcus Biosciences, Inc. |
Jaen Juan C. |
Officer
|
2026-01-05 |
S - D |
29,670 |
21.34 |
633,157.80 |
924,393 |
| RCUS |
Arcus Biosciences, Inc. |
Jaen Juan C. |
Officer
|
2026-01-05 |
S - D |
2,053 |
22.34 |
45,864.02 |
922,340 |
| RCUS |
Arcus Biosciences, Inc. |
Jaen Juan C. |
Officer
|
2026-01-05 |
S - D |
100 |
23.20 |
2,320.00 |
922,240 |
| ARQT |
Arcutis Biotherapeutics, Inc. |
Burnett Patrick |
Officer
|
2026-01-05 |
S - D |
2,490 |
28.98 |
72,165.68 |
94,120 |
| COIN |
Coinbase Global, Inc. |
Armstrong Brian |
Director
Officer
10% Owner
|
2026-01-05 |
M - A |
40,000 |
18.71 |
748,400.00 |
40,000 |
| COIN |
Coinbase Global, Inc. |
Armstrong Brian |
Director
Officer
10% Owner
|
2026-01-05 |
S - D |
20,790 |
248.53 |
5,166,876.33 |
19,210 |
| COIN |
Coinbase Global, Inc. |
Armstrong Brian |
Director
Officer
10% Owner
|
2026-01-05 |
S - D |
18,923 |
249.41 |
4,719,638.41 |
287 |
| COIN |
Coinbase Global, Inc. |
Armstrong Brian |
Director
Officer
10% Owner
|
2026-01-05 |
S - D |
287 |
250.01 |
71,752.84 |
0 |
|
Coinbase Global, Inc. |
Armstrong Brian |
Director
Officer
10% Owner
|
2026-01-05 |
M - D |
40,000 |
0.00 |
0.00 |
2,553,924 |
| AIP |
Arteris, Inc. |
Kunkel Joachim |
|
2026-01-05 |
A - A |
910 |
0.00 |
0.00 |
68,728 |
| AIP |
Arteris, Inc. |
Alpern Paul L |
|
2026-01-05 |
M - A |
2,500 |
9.28 |
23,200.00 |
64,468 |
| AIP |
Arteris, Inc. |
Alpern Paul L |
|
2026-01-05 |
S - D |
2,500 |
16.00 |
40,000.00 |
61,968 |
|
Arteris, Inc. |
Alpern Paul L |
|
2026-01-05 |
M - D |
2,500 |
0.00 |
0.00 |
0 |
| CRCT |
Cricut, Inc. |
Ashish Arora |
Director
Officer
10% Owner
|
2026-01-05 |
S - D |
20,833 |
4.97 |
103,448.34 |
4,219,588 |
|
CAPRICOR THERAPEUTICS, INC. |
Auwaerter Paul Gisbert |
|
2026-01-05 |
A - A |
15,500 |
0.00 |
0.00 |
15,500 |
|
CAPRICOR THERAPEUTICS, INC. |
Auwaerter Paul Gisbert |
|
2026-01-05 |
A - A |
1,360 |
0.00 |
0.00 |
1,360 |
|
CAPRICOR THERAPEUTICS, INC. |
Auwaerter Paul Gisbert |
|
2026-01-05 |
A - A |
5,420 |
0.00 |
0.00 |
5,420 |
| AXSM |
Axsome Therapeutics, Inc. |
TABUTEAU HERRIOT |
|
2026-01-05 |
M - A |
78,703 |
8.02 |
631,198.06 |
85,932 |
| AXSM |
Axsome Therapeutics, Inc. |
TABUTEAU HERRIOT |
|
2026-01-05 |
S - D |
78,703 |
171.28 |
13,480,249.84 |
7,229 |
|
Axsome Therapeutics, Inc. |
TABUTEAU HERRIOT |
|
2026-01-05 |
M - D |
78,703 |
0.00 |
0.00 |
93,121 |
| BCV |
BANCROFT FUND LTD |
GABELLI MARIO J |
Director
Other
|
2026-01-05 |
S - D |
1,300 |
22.25 |
28,931.50 |
25,700 |
| NTLA |
Intellia Therapeutics, Inc. |
BASTA JAMES |
|
2026-01-05 |
S - D |
10,397 |
9.21 |
95,756.37 |
101,528 |
| UTHR |
UNITED THERAPEUTICS Corp |
BENKOWITZ MICHAEL |
|
2026-01-05 |
M - A |
7,875 |
146.03 |
1,149,986.25 |
7,875 |
| UTHR |
UNITED THERAPEUTICS Corp |
BENKOWITZ MICHAEL |
|
2026-01-05 |
S - D |
376 |
480.68 |
180,736.88 |
7,499 |